A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 7, 2013, Pages 1242-1253

  Hu, Hao ^a   Wang, Yu Liang ^a   Wang, Gong Wei ^a   Wong, Yong Chuan ^b   Wang, Xiao Feng ^a   Wang, Ying ^c   Xu, Ke Xin ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Bladder cancer; Epithelial to mesenchymal transition; Id 1

Indexed keywords

ALPHA CATENIN; BETA CATENIN; INHIBITOR OF DIFFERENTIATION 1; NERVE CELL ADHESION MOLECULE; OLIGONUCLEOTIDE; RETROVIRUS VECTOR; SMALL INTERFERING RNA; UVOMORULIN; VIMENTIN;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER GROWTH; CANCER RECURRENCE; CANCER TISSUE; CELL INVASION; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; MUSCLE INVASIVE BLADDER CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; UPREGULATION; WESTERN BLOTTING; WOUND CLOSURE;

BLADDER CANCER; EPITHELIAL-TO-MESENCHYMAL TRANSITION; ID-1;

BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICROSCOPY, CONFOCAL; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RNA INTERFERENCE; URINARY BLADDER NEOPLASMS;

EID: 84884672985     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.12.003     Document Type: Article

References (38)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Soloway M.S., Bruck D.S., Kim S.S. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol 2003, 170:438-441.
3. Nambirajan T., Sohaib S.A., Muller-Pollard C., et al. Virtual cystoscopy from computed tomography: A pilot study. BJU Int 2004, 94:828-831.
4. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: Progression and recurrence. J Urol 1983, 130:1083-1086.
5. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., et al. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 2000, 164:680-684.
6. Benezra R., Davis R.L., Lockshon D., et al. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 1990, 61:49-59.
7. Perk J., Iavarone A., Benezra R. Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 2005, 5:603-614.
8. Yuen H.F., Chan Y.P., Chan K.K., et al. Id-1 and Id-2 are markers for metastasis and prognosis in esophageal squamous cell carcinoma. Br J Cancer 2007, 97:1409-1415.
9. Fong S., Itahana Y., Sumida T., et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 2003, 100:13543-13548.
10. Schindl M., Oberhuber G., Obermair A., et al. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 2001, 61:5703-5706.
11. Kamalian L., Gosney J.R., Forootan S.S., et al. Increased expression of Id family proteins in small cell lung cancer and its prognostic significance. Clin Cancer Res 2008, 14:2318-2325.
12. Li X., Zhang Z., Xin D., et al. Prognostic significance of Id-1 and its association with EGFR in renal cell cancer. Histopathology 2007, 50:484-490.
13. Ouyang X.S., Wang X., Lee D.T., et al. Overexpression of ID-1 in prostate cancer. J Urol 2002, 167:2598-2602.
14. Ding Y., Wang G., Ling M.T., et al. Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion. Int J Oncol 2006, 28:847-854.
15. Hu H., Han H.Y., Wang Y.L., et al. The role of Id-1 in chemosensitivity and epirubicin-induced apoptosis in bladder cancer cells. Oncol Rep 2009, 21:1053-1059.
16. Thiery J.P. Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2002, 2:442-454.
17. Yang J., Mani S.A., Weinberg R.A. Exploring a new twist on tumor metastasis. Cancer Res 2006, 66:4549-4552.
18. Hugo H., Ackland M.L., Blick T., et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007, 213:374-383.
19. Arumugam T., Ramachandran V., Fournier K.F., et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 2009, 69:5820-5828.
20. Clairotte A., Lascombe I., Fauconnet S., et al. Expression of E-cadherin and &;α-, β-, γ-catenins in patients with bladder cancer: Identification of γ-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors. Am J Clin Pathol 2006, 125:119-126.
21. Rieger-Christ K.M., Cain J.W., Braasch J.W., et al. Expression of classic cadherins type I in urothelial neoplastic progression. Hum Pathol 2001, 32:18-23.
22. Kondo M., Cubillo E., Tobiume K., et al. A role for Id in the regulation of TGF-β-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ 2004, 11:1092-1101.
23. Wiercinska E., Wickert L., Denecke B., et al. Id-1 is a critical mediator in TGF-β-induced transdifferentiation of rat hepatic stellate cells. Hepatology 2006, 43:1032-1041.
24. Jorda M., Vinyals A., Marazuela A., et al. Id-1 is induced in MDCK epithelial cells by activated Erk/MAPK pathway in response to expression of the Snail and E47 transcription factors. Exp Cell Res 2007, 313:2389-2403.
25. Ouyang X.S., Wang X., Lee D.T., et al. Overexpression of ID-1 in prostate cancer. J Urol 2002, 167:2598-2602.
26. Bosch F.X., Andl C., Abel U., et al. E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: A comparison of E-cadherin with desmosomal components. Int J Cancer 2005, 114:779-790.
27. Lin C.Q., Singh J., Murata K., et al. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 2000, 60:1332-1340.
28. Bracke M.E., Boterberg T., Bruyneel E.A., et al. Collagen invasion assay. Metastasis research protocols 2001, 81-89. Humana Press, Totowa, NJ. S.A. Brooks, U. Schumacher (Eds.).
29. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7:131-142.
30. Desprez P.Y., Sumida T., Coppe J.P. Helix-loop-helix proteins in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2003, 8:225-239.
31. Ling M.T., Lau T.C., Zhou C., et al. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 2005, 26:1668-1676.
32. Fong S., Itahana Y., Sumida T., et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 2003, 100:13543-13548.
33. Kang Y., Massague J. Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 2004, 118:277-279.
34. Klymkowsky M.W., Savagner P. Epithelial-mesenchymal transition: A cancer researcher's conceptual friend and foe. Am J Pathol 2009, 174:1588-1593.
35. Ling M.T., Wang X., Ouyang X.S., et al. Id-1 expression promotes cell survival through activation of NF-κB signaling pathway in prostate cancer cells. Oncogene 2003, 22:4498-4508.
36. Wang X., Di K., Zhang X., et al. Id-1 promotes chromosomal instability through modification of APC/C activity during mitosis in response to microtubule disruption. Oncogene 2008, 27:4456-4466.
37. Li B., Tsao S.W., Li Y.Y., et al. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int J Cancer 2009, 125:2576-2585.
38. Zhang X., Ling M.T., Wang Q., et al. Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. J Biol Chem 2007, 282:33284-33294.